Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein

Vaccine

Volumn 27, Issue 11, 2009, Pages 1771-1776

  Confer, A W ^a   Ayalew, S ^a   Montelongo, M ^a   Step, D L ^a   Wray, J H ^a   Hansen, R D ^b   Panciera, R J ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b SolidTech Animal Health Inc   (United States)

Author keywords

Cattle; Chimeric protein; Leukotoxin; Mannheimia haemolytica; Outer membrane protein; PlpE; Vaccine

Indexed keywords

BACTERIN; BACTERIUM ANTIBODY; CHIMERIC PROTEIN; CHIMERIC PROTEIN SAC89; LEUKOTOXIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN PLPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CALF (BOVINE); CONTROLLED STUDY; DRUG DOSE COMPARISON; INFECTION RESISTANCE; MANNHEIMIA HAEMOLYTICA; NONHUMAN; PNEUMONIC PASTEURELLOSIS; PRIORITY JOURNAL; RECTUM TEMPERATURE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BODY TEMPERATURE; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; LIPOPROTEINS; MANNHEIMIA HAEMOLYTICA; MOLECULAR SEQUENCE DATA; MUTANT CHIMERIC PROTEINS; PNEUMONIA OF CALVES, ENZOOTIC; VACCINATION;

EID: 60849101822     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.028     Document Type: Article

References (30)

1. Rice J.A., Carrasco-Medina L., Hodgins D.C., and Shewen P.E. Mannheimia haemolytica and bovine respiratory disease. Anim Health Res Rev 8 2 (2007) 117-128
2. Shewen P.E., and Wilkie B.N. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Can J Vet Res 52 1 (1988) 30-36
3. Confer A.W. Immunogens of Pasteurella. Vet Microbiol 37 3-4 (1993) 353-368
4. Confer A.W., Ayalew S., Panciera R.J., Montelongo M., Whitworth L.C., and Hammer J.D. Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine. Vaccine 21 21-22 (2003) 2821-2829
5. Confer A.W., Ayalew S., Panciera R.J., Montelongo M., and Wray J.H. Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge. Vaccine 24 13 (2006) 2248-2255
6. Confer A.W., McCraw R.D., Durham J.A., Morton R.J., and Panciera R.J. Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1. Vet Immunol Immunopathol 47 1-2 (1995) 101-110
7. Lee R.W., Cornelisse M., Ziauddin A., Slack P.J., Hodgins D.C., Strommer J.N., et al. Expression of a modified Mannheimia haemolytica GS60 outer membrane lipoprotein in transgenic alfalfa for the development of an edible vaccine against bovine pneumonic pasteurellosis. J Biotechnol 135 2 (2008) 224-231
8. Morton R.J., Panciera R.J., Fulton R.W., Frank G.H., Ewing S.A., Homer J.T., et al. Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure. Am J Vet Res 56 7 (1995) 875-879
9. Mosier D.A., Simons K.R., Confer A.W., Panciera R.J., and Clinkenbeard K.D. Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis. Infect Immun 57 3 (1989) 711-716
10. Pandher K., Confer A.W., and Murphy G.L. Genetic and immunologic analysis of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica Serotype 1. Infect Immun 66 12 (1998) 5613-5619
11. Pandher K., Murphy G.L., and Confer A.W. Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1. Vet Microbiol 65 3 (1999) 215-226
12. Ayalew S., Confer A.W., and Blackwood E.R. Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE. Infect Immun 72 12 (2004) 7265-7274
13. Ayalew S., Blackwood E.R., and Confer A.W. Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2 and 6. Vet Microbiol 114 3-4 (2006) 260-268
14. Lainson F.A., et al. Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin. Microbiology 142 9 (1996) 2499-2507
15. Rajeev S., et al. Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment. Vaccine 19 32 (2001) 4842-4850
16. Ayalew S., Confer A.W., Garrels K.D., Ingram K., and Montelongo M. Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin. Vaccine 26 38 (2008) 4955-4961
17. Confer A.W., Clinkenbeard K.D., Gatewood D.M., Driskel B.A., and Montelongo M. Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin. Vaccine 15 12-13 (1997) 1423-1429
18. Confer A.W., Fulton R.W., Clinkenbeard K.D., and Driskel B.A. Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines. Vaccine 16 20 (1998) 1962-1970
19. Panciera R.J., and Corstvet R.E. Bovine pneumonic pasteurellosis: model for Pasteurella haemolytica- and Pasteurella multocida-induced pneumonia in cattle. Am J Vet Res 45 12 (1984) 2532-2537
20. Panciera R.J., Corstvet R.E., Confer A.W., and Gresham C.N. Bovine pneumonic pasteurellosis: effect of vaccination with live Pasteurella species. Am J Vet Res. 45 12 (1984) 2538-2542
21. Petrie A., and Watson P. Statistics for veterinary and animal science, vols. 96-98 (1999), Blackwell Press, London p. 81-8, 92-6
22. Confer A.W., Panciera R.J., Fulton R.W., Gentry M.J., and Rummage J.A. Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis. Am J Vet Res 46 2 (1985) 342-347
23. González-Fernández A., and Milstein C. Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation. Immunology 93 2 (1998) 149-153
24. Baker C.J., Rench M.A., Paoletti L.C., and Edwards M.S. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 25 1 (2007) 55-63
25. Roost H.P., Bachmann M.F., Haag A., Kalinke U., Pliska V., Hengartner H., et al. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc Natl Acad Sci USA. 92 5 (1995) 1257-1261
26. Vordermeier H.M., Pontarollo R., Karvonen B., Cockle P., Hecker R., Singh M., et al. Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c. Vaccine 23 35 (2005) 4375-4384
27. Wildman B.K., Perrett T., Abutarbush S.M., Guichon P.T., Pittman T.J., Booker C.W., et al. A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of developing undifferentiated fever/bovine respiratory disease. Can Vet J 49 5 (2008) 463-472
28. Dzata G.K., Wyckoff III J.H., and Confer A.W. Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: an analysis of cellular and humoral immune responses. Vet Microbiol 29 1 (1991) 15-26
29. Dzata G.K., Confer A.W., and Wyckoff III J.H. The effects of adjuvants on immune responses in cattle injected with a Brucella abortus soluble antigen. Vet Microbiol 29 1 (1991) 27-48
30. Hilgers L.A., and Snippe H. DDA as an immunological adjuvant. Res Immunol 143 5 (1992) 494-503